Yi‐Huei Chang
Papers
2
Total Citations
7
H-Index
2
About
Dr. Yi‐Huei Chang is a leading urologic oncologist whose research focuses on upper tract urothelial carcinoma (UTUC), a malignancy that is particularly prevalent in Taiwan, where it constitutes 30–40% of all urothelial cancers. Her major contributions center on evaluating the safety and efficacy of minimally invasive surgical techniques—specifically laparoscopic and robotic approaches—compared to traditional open nephroureterectomy with bladder cuff excision for locally advanced UTUC. In a pivotal 2024 multi-center retrospective study, Dr. Chang demonstrated that minimally invasive surgery can achieve comparable oncologic outcomes to open surgery in patients with T3/T4 disease, challenging prior concerns about its role in advanced stages. Her 2025 work further compared survival outcomes between minimally invasive and open radical nephroureterectomy, providing critical evidence to guide surgical decision-making in high-risk populations. With her studies accumulating citations and shaping clinical practice, Dr. Chang has become a key voice in UTUC management, particularly for Asian populations where the disease burden is highest. Her research not only advances surgical precision but also addresses a pressing regional health disparity, making her work both clinically impactful and globally relevant.
Research Focus
Key Achievements
Top Papers
- 1
- 2